EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Esclerosis múltiple: aspectos inmunológicos actuales

Carlos Cuevas-García

Revista Alergia México · 09.02.2017 · 64 (1) · 76-86

DOI: 10.29262/ram.v64i1.253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Revista Alergia México, online erschienen am 09.02.2017. Verfasst von Carlos Cuevas-García. Beteiligte Einrichtung: Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Dirección General, Ciudad de México, México. cacu…. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis is the most common inflammatory, chronic and degenerative condition of the central nervous system, and represents the first cause of disability in young adults. In Mexico, 11 to 20 out of every 100 000 people suffer from this disease. The causes of multiple sclerosis remain unknown, but several theories have been proposed on its origin: the interaction of environmental factors, viral infectious factors and genetic and immune susceptibility of each individual patient, which induce an autoimmune response and promote neuronal/axonal degeneration. In this review, the immune reaction main components and neurodegeneration present in multiple sclerosis are analyzed, as well as the inflammatory cascade associated with demyelination. Available treatments’ main purpose is to modulate aspects related to the adaptive immune response (B and T cells). The therapeutic challenge will be antigen-specific immune-tolerance induction, for example, with the use of tolerance protocols with peptides or DNA or nanoparticles vaccines. Future therapies should aim to control innate components (microglia, macrophages, astrocytes) and to promote remyelination. To optimize the treatment, a combined therapeutic approach targeting the control of inflammatory and neurodegenerative components of the disease and monitoring of biomarkers will be necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptive ImmunityAstrocytesAxonsCombined Modality TherapyDemyelinating DiseasesGlutathione PeroxidaseHumansImmunity, InnateImmunotherapyInflammationLymphocyte SubsetsMacrophagesMexicoMicrogliaMultiple SclerosisNerve DegenerationOxidative Stress

Stichwörter der Autor:innen

Adaptive immune responseCentral nervous system diseasesMultiple sclerosis

Substanzen

Glutathione Peroxidase

Autor:innen und Institutionen

  • Instituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades, Dirección General, Ciudad de México, México. cacu61152@hotmail.com.

Zitieren

APA

Cuevas-García, C. (2017). Esclerosis múltiple: aspectos inmunológicos actuales. Revista Alergia México, 64(1), 76-86. https://doi.org/10.29262/ram.v64i1.253

Vancouver

Cuevas-García C. Esclerosis múltiple: aspectos inmunológicos actuales. Revista Alergia México. 2017;64(1):76-86. doi:10.29262/ram.v64i1.253

BibTeX
@article{CuevasGarca2017,
  author = {Cuevas-García, Carlos},
  title = {Esclerosis múltiple: aspectos inmunológicos actuales},
  journal = {Revista Alergia México},
  year = {2017},
  volume = {64},
  number = {1},
  pages = {76--86},
  doi = {10.29262/ram.v64i1.253}
}
Kostenlos starten →